ebselen has been researched along with glucagon in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Addabbo, F; Chander, PN; Chen, J; Gobe, G; Goligorsky, MS; Kuo, MC; Li, H; Nasjletti, A; Ni, J; Park, HC; Patschan, D; Pelger, E; Zhang, F | 1 |
1 other study(ies) available for ebselen and glucagon
Article | Year |
---|---|
Adoptive transfer of syngeneic bone marrow-derived cells in mice with obesity-induced diabetes: selenoorganic antioxidant ebselen restores stem cell competence.
Topics: Adoptive Transfer; Amyloid; Animals; Antioxidants; Azoles; Bone Marrow Cells; Bone Marrow Transplantation; Cytokines; Diabetes Mellitus, Type 2; Flow Cytometry; Fluorescent Antibody Technique; Glucagon; Immunohistochemistry; Insulin; Islet Amyloid Polypeptide; Isoindoles; Mice; Mice, Mutant Strains; Obesity; Organoselenium Compounds; Stem Cells; Transplantation, Isogeneic; Vasodilation | 2009 |